Millstone Evans Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167K Buy
1,818
+15
+0.8% +$1.31K 0.09% 171
2026
Q1
$154K Hold
1,803
0.09% 175
2025
Q4
$142K Hold
1,803
0.08% 183
2025
Q3
$144K Hold
1,803
0.09% 164
2025
Q2
$164K Hold
1,803
0.11% 143
2025
Q1
$169K Sell
1,803
-25
-1% -$2.24K 0.11% 137
2024
Q4
$166K Buy
+1,828
New +$174K 0.11% 134

Other funds holding CL

Millstone Evans Group's CL Position: Q2 2026 in Review

Millstone Evans Group increased its Colgate-Palmolive (CL) stake by 0.83% in Q2 2026, buying an estimated $1.31K and bringing the position to 1,818 shares worth $167K. The position accounts for 0.09% of the portfolio, ranked #171.

Millstone Evans Group first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $169K in Q1 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Millstone Evans Group held 1,818 shares of Colgate-Palmolive worth $167K as of Q2 2026.
  • Millstone Evans Group bought 15 Colgate-Palmolive shares in Q2 2026, an estimated $1.31K.
  • Colgate-Palmolive made up 0.09% of Millstone Evans Group's portfolio in Q2 2026, its #171 holding.
  • Millstone Evans Group first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Colgate-Palmolive position peaked at $169K in Q1 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.